Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Lung Cancer (Amsterdam, Netherlands)|May 15, 2012
Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: a case report and review of the literatureYosuke Togashi, Katsuhiro Masago, Yasuhiro Hamatani, et al.
Clinical Lung Cancer|July 9, 2025
Genomic Landscape of Resected Invasive Mucinous Adenocarcinoma of the LungKatsuhiro Masago, Hiroaki Kuroda, Katsutoshi Seto, et al.
Cancer Chemotherapy and Pharmacology|September 10, 2015
EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancerKyoko Otsuka, Akito Hata, Jumpei Takeshita, et al.
Genes, Chromosomes & Cancer|June 1, 2026
Detecting Rare ALK Gene Fusions in Unclassified Spindle Cell Lung Tumors Using Anchored Multiplex PCR/Targeted RNA Next-Generation SequencingKatsuhiro Masago, Katsutoshi Seto, Eiichi Sasaki, et al.
The Journal of International Medical Research|August 2, 2017
Optimal dilution of contrast medium for quantitating parenchymal blood volume using a flat-panel detectorTakumi Kuriyama, Nobuyuki Sakai, Mikiya Beppu, et al.
Oncology|June 15, 2018
Relationship between Paronychia and Drug Concentrations of Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsKatsuhiro Masago, Kei Irie, Shiro Fujita, et al.
Cancer Medicine|December 22, 2023
Changes in serum DAMPs and cytokines/chemokines during near-infrared photoimmunotherapy for patients with head and neck cancerHiromasa Ishihara, Daisuke Nishikawa, Daisuke Muraoka, et al.
General Thoracic and Cardiovascular Surgery|June 3, 2026
Complex versus simple segmentectomy in non-small cell lung cancer: a single-center, retrospective studyKatsutoshi Seto, Yuta Matsubayashi, Osamu Noritake, et al.
Cancer Genetics|September 30, 2022
Association of the KRAS genotype and clinicopathologic findings of resected non-small-cell lung cancer: A pooled analysis of 179 patientsKatsuhiro Masago, Hiroaki Kuroda, Eiichi Sasaki, et al.
Anticancer Research|December 16, 2014
Clinicopathological factors affecting progression-free survival of patients with previously treated advanced non-small cell lung cancer after S-1 therapy with or without bevacizumabKatsuhiro Masago, Shiro Fujita, Akito Hata, et al.
Pageof 13